Sriram Naganathan

Sriram Naganathan currently serves as Vice President of Technical Operations, Drug Substance at REVOLUTION Medicines since February 2023. Previously, Sriram held the position of Executive Director and Head of CMC at Nurix Therapeutics, overseeing outsourced manufacturing and regulatory filings for clinical programs. Sriram has also contributed as Co-chair for the Organic Reactions and Processes Gordon Research Conference and led chemical development efforts at Dermira, where responsibilities included drug substance production for clinical candidates and commercial products. Sriram’s extensive experience includes key roles at Intarcia Therapeutics, Exelixis, CellGate, Roche Bioscience, and Cultor, with a focus on process development and validation. Sriram holds a Ph.D. in Organic Chemistry from the University at Albany, an MS from The University of Kansas, and a B.Sc. in Chemistry from Vivekananda College, University of Madras.